Skip to main content
Back to OrbiMed

OrbiMed's Health Care Portfolio

Browse 123 Health Care companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Health Care Companies
123
Total Funding in Health Care
$12.4B

Health Care Portfolio Companies (123)

Export
BiotechnologyHealth CareTherapeutics

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Cambridge, United States
September 2023
$21.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

Los Angeles, United States
September 2022
$300.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncology

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

San Diego, United States
August 2021
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsPharmaceutical

A private biopharmaceutical company .

Woburn, United States
August 2021
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Lexington, United States
August 2024
$125.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalOncology

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Philadelphia, United States
July 2026
$67.4M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.

Stevenage, United Kingdom
July 2021
$27.6M
Series B

Founder Contacts

41,000+ verified contacts

Health CareMedicalTherapeutics

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Dover, United States
July 2024
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

Health CareHealth DiagnosticsMedical DeviceSoftwareTherapeutics

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

New York, United States
July 2026
$23.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

London, United Kingdom
July 2022
$4.1M
Grant

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical

DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.

Palo Alto, United States
July 2022
$225.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Boston, United States
July 2024
$150.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Lausanne, Switzerland
July 2024
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

Health CareHome Health CareMedical DevicemHealthTelehealth

TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.

New York, United States
July 2026
$25.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
July 2026
$200.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareTherapeutics

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Cambridge, United States
July 2021
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Waltham, United States
June 2023
$200.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscienceTherapeutics

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Cambridge, United States
June 2024
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

New York, United States
June 2026
$250.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMental HealthNeurosciencePharmaceutical

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Toronto, Canada
June 2026
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Austin, United States
June 2023
$210.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.

Watertown, United States
June 2026
$65.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

Vancouver, Canada
May 2022
$105.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Boston, United States
May 2023
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Forte Biosciences is a biotechnology company that focuses on dermatology.

Sherman Oaks, United States
April 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Cambridge, United States
April 2026
$180.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

DentalHealth CareMedicalMedical Device

vVardis develops oral care and dental treatment products using biomimetic peptide technology to address tooth decay and enamel repair.

Baar, Switzerland
April 2026
Private Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsManufacturingMedical Device

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.

Carlsbad, United States
April 2022
$35.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$5.0M
Convertible Note

Founder Contacts

41,000+ verified contacts

Health Care

Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals.

Rochester, United States
April 2026
$50.0M
Private Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

San Diego, United States
April 2026
$30.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Natick, United States
March 2024
$182.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Foster City, United States
March 2026
$2.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

San Diego, United States
March 2025
$20.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth Care

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

South San Francisco, United States
March 2024
$240.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

San Diego, United States
March 2024
$175.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Bothell, United States
March 2025
$110.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyTherapeutics

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Waltham, United States
February 2026
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

San Diego, United States
September 2025
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Watertown, United States
September 2025
$200.0M
Series A

Founder Contacts

41,000+ verified contacts

Health CareMedical Device

ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.

Dublin, Ireland
August 2025
$80.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Oakdale, United States
May 2025
$52.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Raleigh, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

Chicago, United States
July 2024
$45.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Health CareMedical DeviceTherapeutics

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

San Francisco, United States
January 2024
$40.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

New York, United States
January 2024
$100.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareInternetPharmaceutical

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

Oakland, United States
November 2023
$30.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Palo Alto, United States
January 2026
$200.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

London, United Kingdom
January 2025
$411.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Philadelphia, United States
January 2026
$135.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeurosciencePharmaceuticalTherapeutics

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Cambridge, United States
January 2025
$207.5M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalWellness

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Écully, France
January 2023
$138.6M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Lexington, United States
January 2024
$140.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalMedical DevicePharmaceutical

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

Foster City, United States
December 2025
$650.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyFitnessHealth CareWellness

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Duisburg, Germany
December 2021
$98.1M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyData Collection and LabelingHealth CareMedical DeviceWearables

Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.

Boca Raton, United States
December 2025
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife Science

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Cambridge, United States
January 2025
$3.9M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.

New York, United States
December 2021
$1.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.

Sandwich, United Kingdom
December 2024
$140.0M
Series A

Founder Contacts

41,000+ verified contacts

Business IntelligenceHealth CareMedical

Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.

New York, United States
December 2025
$200.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareManufacturingTherapeutics

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

San Francisco, United States
December 2025
$70.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

San Diego, United States
December 2025
$84.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.

Seattle, United States
November 2023
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

Mountain View, United States
January 2025
$32.5M
Undisclosed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

PierianDx is catalyzing global adoption of genomic sequencing in healthcare

St Louis, United States
November 2021
$30.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Electronic Health Record (EHR)Health CareHospitalMedical

Medical documentation, Point-of-care notifications, Structured data, Open ecosystem

San Francisco, United States
November 2023
$25.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

CollaborationComplianceEnterpriseEnterprise SoftwareHealth CareInformation TechnologymHealthProductivity ToolsSaaSSoftware

TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.

Santa Monica, United States
January 2022
$300.0M
Private Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Redwood City, United States
October 2025
$80.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Health Care

Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.

Palm Beach Gardens, United States
October 2023
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Plymouth Meeting, United States
October 2024
$248.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Saint Laurent, Canada
October 2021
$101.2M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth CareOncologyPharmaceuticalTherapeutics

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Cambridge, United States
October 2025
$155.3M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

South San Francisco, United States
October 2023
$100.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Health CareMedicalPharmaceutical

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Menlo Park, United States
October 2022
$125.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

Natick, United States
October 2022
$35.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Basel, Switzerland
October 2022
$125.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Health CareMedicalMedical DeviceNeuroscience

Stairway Medical is a developer of implantable brain-computer interface technology.

Pudong, China
March 2026
$72.6M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaHealth CareMedical

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Changping, China
March 2026
$72.8M
Series C

Founder Contacts

41,000+ verified contacts

Consumer GoodsFast-Moving Consumer GoodsFitnessHealth CareWellness

Started in 2013, Redcliffe Hygiene Private Limited is India's fastest growing hygiene company.

Gurgaon, India
January 2026
$32.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncology

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Beltsville, United States
November 2025
$21.5M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth Care

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

Copenhagen, Denmark
November 2024
$135.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

Tel Aviv, Israel
July 2024
$10.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

Health CareMedicalMedical Device

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Kadima, Israel
July 2024
$105.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BeautyHealth CareHospitalMedical

Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator.

Shenzhen, China
December 2022
Private Equity

Founder Contacts

41,000+ verified contacts

Health CareTrainingWellness

Dami&Xiaomi is a child autism intervention agency.

Shenzhen, China
July 2022
$42.0M
Series D

Founder Contacts

41,000+ verified contacts

AnalyticsBiotechnologyHealth CareMedicalMedical Device

MDClone offers a powerful, self-service data analytics environment enabling healthcare collaboration, research, and innovation.

Be'er Sheva, Israel
March 2022
$63.0M
Series C

Founder Contacts

41,000+ verified contacts

Health CareMedical DeviceRobotics

Edge Medical Robotics is a surgical robot platform company focused on design, R&D, and commercialization of advance medical devices.

Shenzhen, China
November 2021
$200.0M
Series C

Founder Contacts

41,000+ verified contacts

Health CareInformation TechnologyInsuranceInsurTech

Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.

Beijing, China
August 2021
$231.8M
Series F

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareInformation TechnologyPharmaceuticalTravel

Theseus Pharmaceuticals is a technology-based company.

New York, United States
April 2021
$100.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

Philadelphia, United States
January 2021
$154.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Emendo is a biotechnology company

New York, United States
December 2020
$250.0M
Corporate Round

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Cambridge, United States
November 2020
$650.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalPrecision MedicineTherapeutics

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.

San Diego, United States
October 2020
$460.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

BioShin is a clinical stage biopharmaceutical company.

Shanghai, China
September 2020
$60.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

Stevenage, United Kingdom
August 2020
$44.0M
Series C

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedical Device

MobileODT is an AI-based health-tech company that develops medical device technologies for cervical cancer screening.

Tel Aviv, Israel
August 2020
$4.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical Device

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Redwood City, United States
August 2020
$70.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Perfuse Therapeutics specializes in developing therapies for the treatment of eye disease.

San Francisco, United States
July 2020
$9.0M
Series A

Founder Contacts

41,000+ verified contacts

Big DataBiotechnologyHealth CareMedical

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Hangzhou, China
July 2020
$30.0M
Series E

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Protekt Therapeutics is a drug development company aiming to develop inhibitors of PKR for various diseases

Ness Ziona, Israel
November 2019
$4.1M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

Redwood City, United States
August 2019
$80.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.

San Francisco, United States
August 2019
$12.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.

New York, United States
March 2019
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Dallas, United States
February 2019
$150.0M
Series E

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.

Oakland, United States
October 2018
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

KaNDy Therapeutics is a clinical-stage company focused on optimizing the potential of NT-814.

Stevenage, United Kingdom
August 2018
$32.6M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical Device

ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.

Redwood City, United States
January 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth Care

True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.

South San Francisco, United States
January 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

Clinical TrialsHealth CareMedicalPharmaceutical

Tisbury Pharmaceuticals is a pre-clinical stage pharmaceutical company.

Beverly, United States
June 2017
$32.0M
Series A

Founder Contacts

41,000+ verified contacts

Developer PlatformHealth CarePharmaceutical

Rhythm Metabolic develops a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies.

Boston, United States
August 2015
$40.0M
Series A

Founder Contacts

41,000+ verified contacts

BioinformaticsBiotechnologyHealth CarePharmaceutical

Seragon Pharmaceuticals is a research-based company dedicated to improving human and animal health through innovative science.

Irvine, United States
October 2013
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

3D PrintingHealth CareMedical Device

Angelalign is a global service provider of invisible orthodontic technology and invisible orthodontics production and sales.

Shanghai, China
August 2012
$17.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Arteaus Therapeutics is a biotechnology development company focused on creating new therapies to treat migraine.

Cambridge, United States
July 2012
$12.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio